HK inno.N Corporation
195940 | KO
Overview
Corporate Details
- ISIN(s):
- KR7195940002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명2로 239 에이치케이이노엔(주) 오송공장, 청주시
- Website:
- https://www.inno-n.com/eng
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-07-30 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-07-30 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-07-24 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-06-30 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.6 KB | ||
| 2025-06-19 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-07 00:00 |
Regulatory Filings
투자판단관련주요경영사항(임상시험계획승인신청등결정) (IN-B00009의 제3상 임상시험계획 승인)
|
Korean | 10.7 KB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-28 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 14.4 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-28 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.6 KB | ||
| 2025-04-22 00:00 |
Report Publication Announcement
결산실적공시예고
|
Korean | 4.1 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 20.7 KB |
Automate Your Workflow. Get a real-time feed of all HK inno.N Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HK inno.N Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HK inno.N Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Advancing NKT cell modulators for inflammatory, fibrotic, and autoimmune diseases.
United States of America
GRI
United States of America
GRI
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain
GRF
Spain
GRF
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia
GRD1R
Latvia
GRD1R
Offers medical imaging solutions, from contrast agents to AI, for healthcare professionals.
France
GBT
France
GBT
South Korea
036180
Clinical-stage biopharma developing novel drugs for liver fibrosis and pneumoconiosis.
United States of America
GYRE
United States of America
GYRE
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom
HLN
United Kingdom
HLN
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine
GFARM
Ukraine
GFARM
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden
HAMLET
Sweden
HAMLET
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea
009420
South Korea
009420